AJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miller, F. H.
Right arrow Articles by Keppke, A. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miller, F. H.
Right arrow Articles by Keppke, A. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?

MRI of Adenocarcinoma of the Pancreas

Frank H. Miller1, Nancy J. Rini1 and Ana L. Keppke1

1 All authors: Department of Radiology, Northwestern Memorial Hospital, Northwestern University, The Feinberg School of Medicine, 676 N. St. Clair, Ste. 800, Chicago, IL 60611.


Figure 1
View larger version (142K):

[in a new window]
 
Fig. 1A 49-year-old man with small non-contour-deforming pancreatic mass caused by adenocarcinoma. Axial contrast-enhanced MDCT image shows atrophy of pancreatic tail and pancreatic duct dilation (arrow). Discrete mass is difficult to identify.

 

Figure 2
View larger version (112K):

[in a new window]
 
Fig. 1B 49-year-old man with small non-contour-deforming pancreatic mass caused by adenocarcinoma. Axial T2-weighted HASTE MR image (5-mm slice thickness) shows pancreatic ductal dilation (arrow) with associated atrophy of pancreatic tail. Duct dilation is easily seen on T2-weighted images and may be better seen than on MDCT.

 

Figure 3
View larger version (112K):

[in a new window]
 
Fig. 1C 49-year-old man with small non-contour-deforming pancreatic mass caused by adenocarcinoma. Axial venous-phase gadolinium-enhanced T1-weighted fat-suppressed gradient-recalled echo MR image shows 1.8-cm hypointense mass (arrowhead) in pancreatic body, consistent with pancreatic carcinoma. Pancreatic duct dilation (long arrow) and pancreatic atrophy upstream from mass are seen. Ill-defined soft tissue (short arrows) surrounding celiac artery was proven to be malignant.

 

Figure 4
View larger version (155K):

[in a new window]
 
Fig. 2A 31-year-old man with suspected pancreatic mass on MDCT. Axial contrast-enhanced MDCT image shows prominent pancreatic head (arrow) suggesting possibility of subtle mass.

 

Figure 5
View larger version (109K):

[in a new window]
 
Fig. 2B 31-year-old man with suspected pancreatic mass on MDCT. Axial T1-weighted in-phase gradient-recalled echo MR image shows prominent pancreatic head (arrow) with normal signal intensity.

 

Figure 6
View larger version (122K):

[in a new window]
 
Fig. 2C 31-year-old man with suspected pancreatic mass on MDCT. Axial T1-weighted opposed-phase gradient-recalled echo MR image shows signal dropout in pancreatic head (arrow) because of fatty infiltration without evidence of underlying mass.

 

Figure 7
View larger version (125K):

[in a new window]
 
Fig. 2D 31-year-old man with suspected pancreatic mass on MDCT. Axial arterial-phase gadolinium-enhanced T1-weighted fat-suppressed gradient-recalled echo MR image shows normal homogeneous enhancement of head of pancreas (arrow) without mass.

 

Figure 8
View larger version (100K):

[in a new window]
 
Fig. 3A 60-year-old man with mass in uncinate process of pancreas that proved to be pancreatic adenocarcinoma. Patient had elevated creatinine and could not receive iodinated contrast material on CT. Coronal T2-weighted RARE MR cholangiopancreatography image shows dilation of common bile duct (short arrow) and pancreatic duct (long arrow) with abrupt termination at confluence of ducts (arrowhead). This double duct sign is highly suspicious for malignancy.

 

Figure 9
View larger version (129K):

[in a new window]
 
Fig. 3B 60-year-old man with mass in uncinate process of pancreas that proved to be pancreatic adenocarcinoma. Patient had elevated creatinine and could not receive iodinated contrast material on CT. Axial late arterial-phase gadolinium-enhanced T1-weighted fat-suppressed gradient-recalled echo MR image shows 2.5-cm hypointense mass (short arrow) in head of pancreas responsible for double duct sign seen on MR cholangiopancreatography. Fat plane between superior mesenteric artery and pancreatic mass (long arrow) is obscured, suggesting vascular invasion.

 

Figure 10
View larger version (160K):

[in a new window]
 
Fig. 4A 55-year-old man with pancreatic adenocarcinoma and suspected liver metastases shown by MRI but inconspicuous on MDCT. Axial venous-phase contrast-enhanced MDCT image shows hypodense mass (arrow) in pancreatic head. Note homogeneous liver enhancement, without evidence of metastases.

 

Figure 11
View larger version (128K):

[in a new window]
 
Fig. 4B 55-year-old man with pancreatic adenocarcinoma and suspected liver metastases shown by MRI but inconspicuous on MDCT. Axial arterial-phase gadolinium-enhanced T1-weighted fat-suppressed gradient-recalled echo MR image performed 3 days after MDCT shows several ring-enhancing liver lesions (short white arrows) suggestive of liver metastases. These lesions were not bright on T2-weighted images, suggesting bile lakes or abscesses. Patient was afebrile. These lesions were inconspicuous on MDCT. There is susceptibility artifact because of biliary stent (arrowhead) with adjacent dilated pancreatic duct en face (long arrow). Note poorly defined hypointense mass (black arrow) in pancreatic head.

 

Figure 12
View larger version (129K):

[in a new window]
 
Fig. 4C 55-year-old man with pancreatic adenocarcinoma and suspected liver metastases shown by MRI but inconspicuous on MDCT. Axial venous-phase gadolinium-enhanced T1-weighted fat-suppressed gradient-recalled echo MR image confirms the ring-enhancing lesions (arrows).

 

Figure 13
View larger version (119K):

[in a new window]
 
Fig. 5A 55-year-old man with metastatic pancreatic adenocarcinoma. Axial T2-weighted HASTE MR image shows multiple, moderately hyperintense liver lesions (arrows) caused by metastases.

 

Figure 14
View larger version (124K):

[in a new window]
 
Fig. 5B 55-year-old man with metastatic pancreatic adenocarcinoma. Axial unenhanced T1-weighted fat-suppressed gradient-recalled echo MR image shows multiple hypointense liver masses (arrows).

 

Figure 15
View larger version (130K):

[in a new window]
 
Fig. 5C 55-year-old man with metastatic pancreatic adenocarcinoma. Axial arterial-phase gadolinium-enhanced T1-weighted fat-suppressed gradient-recalled echo MR image shows ring-enhancing lesions (white arrows) and wedge-shaped perilesional enhancement (black arrows) of metastases.

 

Figure 16
View larger version (123K):

[in a new window]
 
Fig. 6 57-year-old woman with newly diagnosed pancreatic carcinoma and peritoneal metastases. Axial venous-phase gadolinium-enhanced T1-weighted fat-suppressed gradient-recalled echo MR image shows right-sided peritoneal implant (black arrow). Hypointense pancreatic mass (open arrow) and pseudocyst (short white arrow) are seen. Mass in left adrenal gland (long arrow) does not have imaging characteristics of adenoma on other imaging sequences and may represent metastasis or lipid-poor adenoma.

 

Figure 17
View larger version (126K):

[in a new window]
 
Fig. 7A 53-year-old man with pancreatic carcinoma metastatic to liver and greater omentum. Axial unenhanced T1-weighted fat-suppressed gradient-recalled echo MR image shows low-signal-intensity lesions (arrows) in liver, consistent with metastases.

 

Figure 18
View larger version (135K):

[in a new window]
 
Fig. 7B 53-year-old man with pancreatic carcinoma metastatic to liver and greater omentum. Axial gadolinium-enhanced T1-weighted fat-suppressed gradient-recalled echo MR image shows enhancement along left side of greater omentum (arrow), consistent with metastases. Hypointense liver metastases (arrowheads) are also identified.

 

Figure 19
View larger version (154K):

[in a new window]
 
Fig. 8A 36-year-old man with clinical history of pancreatitis was subsequently proven to have pancreatic carcinoma with axillary lymph node metastases. Axial arterial-phase contrast-enhanced MDCT image shows prominence of pancreatic tail (arrow), mild peripancreatic fat stranding, and multiple retroperitoneal lymph nodes (arrowheads).

 

Figure 20
View larger version (121K):

[in a new window]
 
Fig. 8B 36-year-old man with clinical history of pancreatitis was subsequently proven to have pancreatic carcinoma with axillary lymph node metastases. Axial unenhanced T1-weighted fat-suppressed gradient-recalled echo MR image shows subtle enlargement of pancreatic tail (arrow) and multiple small lymph nodes (arrowheads) along celiac artery.

 

Figure 21
View larger version (130K):

[in a new window]
 
Fig. 8C 36-year-old man with clinical history of pancreatitis was subsequently proven to have pancreatic carcinoma with axillary lymph node metastases. Axial venous-phase gadolinium-enhanced T1-weighted fat-suppressed gradient-recalled echo MR image shows pancreatic tail mass (arrow), which proved to be pancreatic carcinoma, more conspicuously than MDCT. Multiple retroperitoneal lymph nodes (arrowheads) are also identified around celiac artery.

 

Figure 22
View larger version (142K):

[in a new window]
 
Fig. 9A 59-year-old man with unexplained acute recurrent pancreatitis on MDCT examinations performed 2 years apart. The patient subsequently proved to have pancreatic carcinoma. Axial arterial-phase contrast-enhanced MDCT image from 2002 shows nonenhancing, ill-defined pancreatic body (white arrow) with moderate peripancreatic fat stranding and fluid (arrowheads), which is consistent with pancreatitis. Normal enhancement in pancreatic tail is seen (black arrow).

 

Figure 23
View larger version (124K):

[in a new window]
 
Fig. 9B 59-year-old man with unexplained acute recurrent pancreatitis on MDCT examinations performed 2 years apart. The patient subsequently proved to have pancreatic carcinoma. Axial arterial-phase contrast-enhanced MDCT image from 2004 shows poorly defined, nonenhancing pancreatic body and tail suggestive of necrosis (white arrow). There were findings suggestive of pancreatic mass (black arrow).

 

Figure 24
View larger version (137K):

[in a new window]
 
Fig. 9C 59-year-old man with unexplained acute recurrent pancreatitis on MDCT examinations performed 2 years apart. The patient subsequently proved to have pancreatic carcinoma. Axial T2-weighted HASTE MR image performed 3 weeks after MDCT (B) shows pancreatic duct dilation and atrophy of pancreatic tail (arrow).

 

Figure 25
View larger version (117K):

[in a new window]
 
Fig. 9D 59-year-old man with unexplained acute recurrent pancreatitis on MDCT examinations performed 2 years apart. The patient subsequently proved to have pancreatic carcinoma. Axial unenhanced T1-weighted fat-suppressed gradient-recalled echo MR image at lower level than C shows mass (arrow) in body of pancreas. Bowel (arrowhead) is seen adjacent to pancreatic mass.

 

Figure 26
View larger version (119K):

[in a new window]
 
Fig. 9E 59-year-old man with unexplained acute recurrent pancreatitis on MDCT examinations performed 2 years apart. The patient subsequently proved to have pancreatic carcinoma. Axial gadolinium-enhanced T1-weighted fat-suppressed gradient-recalled echo MR image shows hypointense mass (arrow) suspicious for tumor in body of pancreas. Endoscopic sonography with biopsy showed adenocarcinoma. Bowel (arrowhead) is seen adjacent to pancreatic mass.

 

Figure 27
View larger version (136K):

[in a new window]
 
Fig. 10A 55-year-old man with metastatic pancreatic carcinoma. Axial T2-weighted HASTE MR image shows multiple periaortic lymph nodes (white arrows) and hyperintense metastasis (black arrow) in liver and paraspinal muscles (arrowhead).

 

Figure 28
View larger version (135K):

[in a new window]
 
Fig. 10B 55-year-old man with metastatic pancreatic carcinoma. Axial gadolinium-enhanced T1-weighted fat-suppressed gradient-recalled echo MR image shows multiple, ring-enhancing, periaortic lymph nodes (short arrows). Ring-enhancing liver metastasis (arrowhead) and multiple enhancing foci (long arrows) in paraspinal muscles caused by metastases are seen.

 

Figure 29
View larger version (122K):

[in a new window]
 
Fig. 11A 49-year-old man with locally advanced pancreatic carcinoma. Axial gadolinium-enhanced T1-weighted fat-suppressed gradient-recalled echo MR image shows abnormal enhancing soft tissue (arrows) surrounding celiac artery, which is suspicious for vascular encasement.

 

Figure 30
View larger version (121K):

[in a new window]
 
Fig. 11B 49-year-old man with locally advanced pancreatic carcinoma. Coronal gadolinium-enhanced T1-weighted fat-suppressed gradient-recalled echo MR image shows abnormal soft tissue (arrow) surrounding origin of celiac and superior mesenteric arteries. This tissue was positive for malignancy by fine-needle aspiration.

 

Figure 31
View larger version (149K):

[in a new window]
 
Fig. 11C 49-year-old man with locally advanced pancreatic carcinoma. Corresponding axial MDCT image shows abnormal soft tissue surrounding celiac axis (arrows).

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Roentgen Ray Society.